Cargando…
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study
The advent of direct-acting antivirals (DAAs) has transformed the landscape of hepatitis C virus (HCV) management. We aimed to prospectively (real-time) evaluate the feasibility of using a response-guided therapy approach, based on mathematical modeling of early viral kinetics, to reduce the duratio...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575564/ https://www.ncbi.nlm.nih.gov/pubmed/33082372 http://dx.doi.org/10.1038/s41598-020-74568-x |